These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28457009)

  • 21. Characterization of plasma and lung concentrations after ceftiofur sodium and tilmicosin phosphate administered subcutaneously to mice.
    Brown SA; Deleeuw NR; Stahl GL; Roof RD
    J Vet Pharmacol Ther; 1995 Oct; 18(5):385-7. PubMed ID: 8587160
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetic behaviour of enrofloxacin and its metabolite ciprofloxacin after subcutaneous administration in cattle.
    de Lucas JJ; San Andrés MI; González F; Froyman R; Rodríguez C
    Vet Res Commun; 2008 Apr; 32(4):275-9. PubMed ID: 18247149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of enrofloxacin and ceftiofur in plasma, interstitial fluid, and gastrointestinal tract of calves after subcutaneous injection, and bactericidal impacts on representative enteric bacteria.
    Foster DM; Jacob ME; Warren CD; Papich MG
    J Vet Pharmacol Ther; 2016 Feb; 39(1):62-71. PubMed ID: 25989138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of enrofloxacin and ciprofloxacin in Atlantic horseshoe crabs (Limulus polyphemus) after single injection.
    Kirby A; Lewbart GA; Hancock-Ronemus A; Papich MG
    J Vet Pharmacol Ther; 2018 Apr; 41(2):349-353. PubMed ID: 29067728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elimination of tilmicosin in lactating ewes.
    Atef M; Abo el-Sooud K; Nahed E; Tawfik M
    Dtsch Tierarztl Wochenschr; 1999 Jul; 106(7):291-4. PubMed ID: 10481373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of tilmicosin in equine tissues and plasma.
    Clark C; Dowling PM; Ross S; Woodbury M; Boison JO
    J Vet Pharmacol Ther; 2008 Feb; 31(1):66-70. PubMed ID: 18177321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of enrofloxacin following oral and subcutaneous administration in the common ringtail possum (Pseudocheirus peregrinus).
    Scheelings TF; Devi JL; Woodward AP; Whittem T
    J Vet Pharmacol Ther; 2015 Oct; 38(5):482-7. PubMed ID: 25622984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-inflammatory benefits of tilmicosin in calves with Pasteurella haemolytica-infected lungs.
    Chin AC; Morck DW; Merrill JK; Ceri H; Olson ME; Read RR; Dick P; Buret AG
    Am J Vet Res; 1998 Jun; 59(6):765-71. PubMed ID: 9622749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. POPULATION PHARMACOKINETICS OF ENROFLOXACIN AND ITS METABOLITE CIPROFLOXACIN IN THE GREEN SEA URCHIN (STRONGYLOCENTROTUS DROEBACHIENSIS) FOLLOWING INTRACOELOMIC AND IMMERSION ADMINISTRATION.
    Phillips BE; Harms CA; Lewbart GA; Lahner LL; Haulena M; Rosenberg JF; Papich MG
    J Zoo Wildl Med; 2016 Mar; 47(1):175-86. PubMed ID: 27010278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrapulmonary concentration of enrofloxacin in healthy calves.
    Otomaru K; Hirata M; Ikedo T; Horinouchi C; Noguchi M; Ishikawa S; Nagata S; Hobo S
    J Vet Med Sci; 2016 May; 78(4):681-3. PubMed ID: 26668174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of tilmicosin and cephapirin as therapeutics for Staphylococcus aureus mastitis at dry-off.
    Nickerson SC; Owens WE; Fox LK; Scheifinger CC; Shryock TR; Spike TE
    J Dairy Sci; 1999 Apr; 82(4):696-703. PubMed ID: 10212455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic behavior of enrofloxacin and its metabolite ciprofloxacin in urutu pit vipers (Bothrops alternatus) after intramuscular administration.
    Waxman S; Prados AP; de Lucas JJ; San Andrés MI; Regner P; de Oliveira VC; de Roodt A; Rodríguez C
    J Zoo Wildl Med; 2014 Mar; 45(1):78-85. PubMed ID: 24712165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tilmicosin enteric granules and premix to pigs: Antimicrobial susceptibility testing and comparative pharmacokinetics.
    Xiong J; Zhu Q; Zhao Y; Yang S; Cao J; Qiu Y
    J Vet Pharmacol Ther; 2019 May; 42(3):336-345. PubMed ID: 30801755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elimination kinetics of tilmicosin following intramammary administration in lactating dairy cattle.
    Smith GW; Davis JL; Baynes RE; Yeatts JL; Barlow BM; Riviere JE
    J Am Vet Med Assoc; 2009 Jan; 234(2):245-8. PubMed ID: 19210246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of optimized bronchoalveolar lavage sampling designs for characterization of pulmonary drug distribution.
    Clewe O; Karlsson MO; Simonsson US
    J Pharmacokinet Pharmacodyn; 2015 Dec; 42(6):699-708. PubMed ID: 26316105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrapulmonary Pharmacokinetics of Levonadifloxacin following Oral Administration of Alalevonadifloxacin to Healthy Adult Subjects.
    Rodvold KA; Gotfried MH; Chugh R; Gupta M; Yeole R; Patel A; Bhatia A
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of tildipirosin in bovine plasma, lung tissue, and bronchial fluid (from live, nonanesthetized cattle).
    Menge M; Rose M; Bohland C; Zschiesche E; Kilp S; Metz W; Allan M; Röpke R; Nürnberger M
    J Vet Pharmacol Ther; 2012 Dec; 35(6):550-9. PubMed ID: 22188102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tilmicosin reduces lipopolysaccharide-stimulated bovine alveolar macrophage prostaglandin E(2) production via a mechanism involving phospholipases.
    Lakritz J; Tyler JW; Marsh AE; Romesburg-Cockrell M; Smith K; Holle JM
    Vet Ther; 2002; 3(1):7-21. PubMed ID: 12050824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and pharmacodynamics of tilmicosin in sheep and cattle.
    Modric S; Webb AI; Derendorf H
    J Vet Pharmacol Ther; 1998 Dec; 21(6):444-52. PubMed ID: 9885967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma and ear tissue concentrations of enrofloxacin and its metabolite ciprofloxacin in dogs with chronic end-stage otitis externa after intravenous administration of enrofloxacin.
    Cole LK; Papich MG; Kwochka KW; Hillier A; Smeak DD; Lehman AM
    Vet Dermatol; 2009 Feb; 20(1):51-9. PubMed ID: 19152587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.